Magnesium acetyltaurate
Magnesium acetyltaurate has been studied in 1 paper since 2026: none in people yet, 1 review; 1 in the past year. No study of it in people or animals has been published yet. The newest paper, Feb 23, 2026: “Magnesium acetyltaurate and ocular neurodegenerative diseases: A review”.
See all 1 papers on magnesium acetyltaurate
What did studies of magnesium acetyltaurate find?
3Studies of magnesium acetyltaurate measured 3 outcomes: glaucoma, inflammation and oxidative stress and ROS signaling.
Glaucoma
downin reviews1
1 study
Glaucoma
downin reviews1
Magnesium acetyltaurate decreases glaucoma in ocular diseases.
“helped reduce glaucomatous changes, mitigated retinal damage caused by hyperglycemia in DR, and inhibited inflammation in AMD.”
Reviewin ocular diseases
Magnesium acetyltaurate and ocular neurodegenerative diseases: A review
Indian Journal of Clinical and Experimental Ophthalmology
Inflammation
downin reviews1
1 study
Inflammation
downin reviews1
Magnesium acetyltaurate decreases inflammation in ocular neurodegenerative diseases.
“MgAT shows significant promise as a therapeutic agent for ocular diseases, particularly in reducing oxidative stress, neuroinflammation, and retinal cell damage.”
Reviewin ocular neurodegenerative diseases
Magnesium acetyltaurate and ocular neurodegenerative diseases: A review
Indian Journal of Clinical and Experimental Ophthalmology
Oxidative stress and ROS signaling
downin reviews1
1 study
Oxidative stress and ROS signaling
downin reviews1
Magnesium acetyltaurate decreases oxidative stress and ROS signaling in ocular neurodegenerative diseases.
“MgAT shows significant promise as a therapeutic agent for ocular diseases, particularly in reducing oxidative stress, neuroinflammation, and retinal cell damage.”
Reviewin ocular neurodegenerative diseases
Magnesium acetyltaurate and ocular neurodegenerative diseases: A review
Indian Journal of Clinical and Experimental Ophthalmology